Sanofi agreed to pay up to 320 million euros ($352.4 million) to U.S. company RadioMedix and the biotechnology subsidiary of nuclear-fuel supplier Orano to license a potential treatment for rare ...
Advisors Capital Management partner and portfolio manager JoAnne Feeney joins Morning Brief to discuss the political outlook for small caps (^RUT) and some of her top tech plays as the market ...
Some results have been hidden because they may be inaccessible to you